Change of Lifestyle in Elderly Patients With Type 2 Diabetes and Systemic Arterial Hypertension
Primary Purpose
Diabetes, Hypertension
Status
Completed
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
DASH
DASHPED
Sponsored by

About this trial
This is an interventional other trial for Diabetes focused on measuring Diabetes, Hypertension, Elderly, DASH, Steps
Eligibility Criteria
Inclusion Criteria:
- Age 60 years or more
- Diabetes Mellitus
- Hypertension with poor control
Exclusion Criteria:
- Glucocorticoid use
- Unstable angina
- Acute myocardial infarction in the last 6 months
- Heart failure classes III and IV
- history of cirrhosis, alcoholism or use of illicit drugs
- Dementia and malignant disease that compromises survival in 5 years
- Serum creatinine greater than 2, 0mg / dl
- BMI> 40 kg / m²
- Physical disability that prevents the use of a pedometer
- Participating in another research project involving any type of intervention.
Sites / Locations
- Hospital de Clínicas de Porto Alegre
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
Other
Arm Label
DASH diet only
DASH diet with pedometer
Arm Description
Patients receive a DASH diet and orientation to maintain their physical activity
Patients receive a DASH diet and orientation to increase their physical activity with a pedometer steps count
Outcomes
Primary Outcome Measures
Change from Baseline Blood Pressure at 4 months
24 hours ambulatory blood pressure monitoring (ABPM)
Secondary Outcome Measures
Change from Baseline Insulin Sensitivity at 4 months
HOMA index (using serum fasting insulin and glucose)
Change from Baseline Glucose Profile at 4 months
Fasting glucose and A1C
Change from Baseline Weight at 4 months anthropometric variables
weight in kilograms
Change from Baseline BMI at 4 months
BMI in kg/m2
Change from Baseline Skeletal muscle mass at 4 months
Skeletal muscle mass in Kilograms
Change from Baseline Body fat mass at 4 months
Body fat mass in kilograms
Change from Baseline Percent body Fat at 4 months
Percent body Fat (%)
Change from Baseline Total cholesterol at 4 months
Total cholesterol in mg/dl
Change from Baseline LDL cholesterol at 4 months
LDL cholesterol in mg/dl
Change from Baseline Triglycerides at 4 months
Triglycerides in mg/dl
Change from Baseline HDL cholesterol at 4 months
HDL cholesterol in mg/dl
Full Information
NCT ID
NCT04863755
First Posted
April 8, 2021
Last Updated
April 26, 2021
Sponsor
Hospital de Clinicas de Porto Alegre
Collaborators
Federal University of Health Science of Porto Alegre
1. Study Identification
Unique Protocol Identification Number
NCT04863755
Brief Title
Change of Lifestyle in Elderly Patients With Type 2 Diabetes and Systemic Arterial Hypertension
Official Title
Change of Lifestyle in Elderly Patients With Type 2 Diabetes and Systemic Arterial Hypertension: Effects of DASH Diet and Physical Activity on Blood Pressure and Insulin Sensitivity
Study Type
Interventional
2. Study Status
Record Verification Date
April 2021
Overall Recruitment Status
Completed
Study Start Date
May 9, 2017 (Actual)
Primary Completion Date
March 18, 2020 (Actual)
Study Completion Date
March 18, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospital de Clinicas de Porto Alegre
Collaborators
Federal University of Health Science of Porto Alegre
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Evaluate the effect of lifestyle modification through the adoption of a DASH diet, with and without physical activity guidance, on blood pressure and insulin sensitivity in elderly patients with type 2 diabetes and hypertension.
Detailed Description
Data regarding the effects of physical activity and DASH-type diet on blood pressure control in patients with type 2 diabetes and hypertension are scarce in the literature, whether evaluating these isolated interventions or together. In addition, most studies do not measure BP using ABPM, which has a special importance in the assessment of pressure homeostasis in DM or are short-term studies. Were only two studies have been identified in the literature that evaluated the effect of the DASH diet on patients with type 2 DM; however, in both trials, being elderly was not an inclusion criterion. The first was an Iranian study that demonstrated in 31 non-hypertensive patients a significant reduction in BP after 8 weeks of following a DASH diet. In the second ECR, we demonstrated that in 20 hypertensive type 2 DM patients, all using antihypertensive drugs and with uncontrolled BP, a DASH-type diet for 4 weeks associated with physical activity reduced the systolic BP assessed by ABPM by 12.5 mmHg. However, the adopted design did not allow to separate the effect of diet from the effect of physical activity. On the other hand, the effect of a single session of walking followed by a 24-hour ABPM assessment showed a reduction in BP in hypertensive elderly and non-hypertensive patients, also without DM. So far it is not defined in patients with type 2 DM and hypertension, especially the elderly, whether the DASH diet alone is as beneficial for BP as its association with physical activity, particularly, considering the difficulties of performing exercises in this group of patients. This is valuable information, as it would reinforce the role of diet therapy intervention even if in isolation in this age group. Furthermore, the role of the DASH diet with or without physical activity remains unknown on insulin sensitivity.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes, Hypertension
Keywords
Diabetes, Hypertension, Elderly, DASH, Steps
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Sequential Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
37 (Actual)
8. Arms, Groups, and Interventions
Arm Title
DASH diet only
Arm Type
Other
Arm Description
Patients receive a DASH diet and orientation to maintain their physical activity
Arm Title
DASH diet with pedometer
Arm Type
Other
Arm Description
Patients receive a DASH diet and orientation to increase their physical activity with a pedometer steps count
Intervention Type
Behavioral
Intervention Name(s)
DASH
Intervention Description
Patients receive DASH diet orientation and recommended to maintain their usual physical activity
Intervention Type
Behavioral
Intervention Name(s)
DASHPED
Intervention Description
Patients receive DASH diet orientation and recommended to increase their usual activity with the use of a pedometer
Primary Outcome Measure Information:
Title
Change from Baseline Blood Pressure at 4 months
Description
24 hours ambulatory blood pressure monitoring (ABPM)
Time Frame
Baseline and 4 months
Secondary Outcome Measure Information:
Title
Change from Baseline Insulin Sensitivity at 4 months
Description
HOMA index (using serum fasting insulin and glucose)
Time Frame
Baseline and 4 months
Title
Change from Baseline Glucose Profile at 4 months
Description
Fasting glucose and A1C
Time Frame
Baseline and 4 months
Title
Change from Baseline Weight at 4 months anthropometric variables
Description
weight in kilograms
Time Frame
Baseline and 4 months
Title
Change from Baseline BMI at 4 months
Description
BMI in kg/m2
Time Frame
Baseline and 4 months
Title
Change from Baseline Skeletal muscle mass at 4 months
Description
Skeletal muscle mass in Kilograms
Time Frame
Baseline and 4 months
Title
Change from Baseline Body fat mass at 4 months
Description
Body fat mass in kilograms
Time Frame
Baseline and 4 months
Title
Change from Baseline Percent body Fat at 4 months
Description
Percent body Fat (%)
Time Frame
Baseline and 4 months
Title
Change from Baseline Total cholesterol at 4 months
Description
Total cholesterol in mg/dl
Time Frame
Baseline and 4 months
Title
Change from Baseline LDL cholesterol at 4 months
Description
LDL cholesterol in mg/dl
Time Frame
Baseline and 4 months
Title
Change from Baseline Triglycerides at 4 months
Description
Triglycerides in mg/dl
Time Frame
Baseline and 4 months
Title
Change from Baseline HDL cholesterol at 4 months
Description
HDL cholesterol in mg/dl
Time Frame
Baseline and 4 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
65 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age 60 years or more
Diabetes Mellitus
Hypertension with poor control
Exclusion Criteria:
Glucocorticoid use
Unstable angina
Acute myocardial infarction in the last 6 months
Heart failure classes III and IV
history of cirrhosis, alcoholism or use of illicit drugs
Dementia and malignant disease that compromises survival in 5 years
Serum creatinine greater than 2, 0mg / dl
BMI> 40 kg / m²
Physical disability that prevents the use of a pedometer
Participating in another research project involving any type of intervention.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Luciana Verçoza Viana
Organizational Affiliation
Hospital de Clínicas de Porto Alegre
Official's Role
Study Director
Facility Information:
Facility Name
Hospital de Clínicas de Porto Alegre
City
Porto Alegre
State/Province
Rio Grande Do Sul
ZIP/Postal Code
90035-903
Country
Brazil
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
after publication
Learn more about this trial
Change of Lifestyle in Elderly Patients With Type 2 Diabetes and Systemic Arterial Hypertension
We'll reach out to this number within 24 hrs